ARCHIVES

Sandra Swain at ASCO 2013: Let’s Focus on Three Goals

This article is from The Cancer Letter archive.

Vol. 39 No. 23 | June 7, 2013

Download PDF Visit The Full Archive

Related Articles

West Coast Symposium Reports Research Progress On Bone Cancer

November 1, 1974

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

November 19, 2004

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials

May 10, 2002

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009